Monarch Partners Asset Management LLC Natera, Inc. Transaction History

Monarch Partners Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$28.13 - $44.54 $1.42 Million - $2.24 Million	-50,350 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$30.32 - $91.33 $1,364 - $4,109	-45 Reduced 0.09%	50,350 $2.05 Million
Q4 2021 Feb 03, 2022	SELL	$86.26 - $119.0 $773,320 - $1.07 Million	-8,965 Reduced 15.1%	50,395 $4.71 Million
Q3 2021 Nov 04, 2021	BUY	$100.17 - $126.36 $5.95 Million - $7.5 Million	59,360 New	59,360 $6.62 Million
Q3 2018 Nov 01, 2018	SELL	$18.82 - $28.96 $357,391 - $549,950	-18,990 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$8.79 - $19.98 $166,922 - $379,420	18,990 New	18,990 $357,000

547

118M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monarch Partners Asset Management LLC with notifications on news.